ArticleBiomedicines2020

Novel Nargenicin A1 Analog Inhibits Angiogenesis by Downregulating the Endothelial VEGF/VEGFR2 Signaling and Tumoral HIF-1α/VEGF Pathway.

Jang Mi Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.